20th International Congress » Epidemiology

Date: Monday, June 20, 2016

Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Session Type: Poster Session

Meeting: 20th International Congress

12:30pm-2:00pm: Appendicitis and risk of Parkinson’s disease: A Danish nationwide population-based cohort study

E. Svensson, E. Horváth-Puhó, M. Stockholm, H. Toft-Sørensen, P. Borghammer (Aarhus N, Denmark)

12:30pm-2:00pm: Are inflammatory bowel disease and/or treatment with aminosalicylates protective factors against Parkinson’s disease?

F. Escamilla-Sevilla, J. Pinel-Ríos, C.J. Madrid-Navarro, R. Piñar-Morales, J.D. Herrera-García, M.J. Pérez-Navarro, C. Del Canto-Pérez, M.J. Cabello-Tapia, M.d.m. Martín-Rodríguez, D. Sánchez-Capilla, M.J. Piña-Vera, A. Aguilar-Muñoz, V. Campos-Arillo, J. Gutiérrez-García, C.E. Chamorro-Santos, M.R. Gómez-García, A. Mínguez-Castellanos (Granada, Spain)

12:30pm-2:00pm: Association of UV radiation with Parkinson’s disease incidence: A nationwide French ecologic study

A. Elbaz, K. Sofiane, L. Wald, A. Dugravot, A. Singh-Manoux, F. Moisan, A. Kravietz (Villejuif, France)

12:30pm-2:00pm: Burden of movement disorders in Cameroon: In/out patient population study

J.N. Doumbe, Y. Mapoure, E. Cubo, T. Nyinyikua, K. Kompoliti (Douala, Cameroon)

12:30pm-2:00pm: Cancer comorbidity among PD patients; a population based large-scale cohort study

R. Gurel, N. Giladi, V. Rozani, T. Gurevich, B. El-Ad, B. Hemo, J. Tsamir, C. Peretz (Tel Aviv, Israel)

12:30pm-2:00pm: Cardiometabolic syndrome and risk of Parkinson’s disease: A case-control study in Mexican population

G. Parra-López, L. Bazán-Rodríguez, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. Jorge de Saráchaga, M. Escobar-Barrios, E. Carreón-Bautista (Mexico City, Mexico)

12:30pm-2:00pm: Cardiovascular and cerebrovascular disorders are associated with a higher prevalence of parkinsonism: Data from a neuroepidemiologic community-based survey

S.M. Fereshtehnejad, M. Shafieisabet, A. Rahmani, A. Delbari, J. Lökk (Stockholm, Sweden)

12:30pm-2:00pm: Characteristics of patients initiating droxidopa for the treatment of neurogenic orthostatic hypotension (nOH)

C. Francois, K. McLeod, A. Duhig, A. Ogbonnaya, A. Quillen, J. Cannon, B. Padilla, C.A. Shibao, I. Biaggioni (Deerfield, IL, USA)

12:30pm-2:00pm: Comorbid conditions associated with Parkinson´s disease: A longitudinal study

D. Santos García, E. Suarez Castro, I. Expósito, T. de Deus, C. Tuñas, D. Núñez Arias, Á. Aneiros, M. López Fernández, J. Naveiro, J. Abella, M.A. Llaneza, V. Vilas, M. Macías (Ferrol, Spain)

12:30pm-2:00pm: Comparing psychosocial risk factors in patients with functional movement disorders and patients with psychogenic non-epileptic seizures

C.W. Maurer, G.M. Capitan, G. Limachia, K. LaFaver, E. Considine, A. Curran, W.C. LaFrance, M. Hallett (Bethesda, MD, USA)

12:30pm-2:00pm: Consumption of Yerba Mate (Ilex Paraguariensis) in Parkinson’s disease patients from Uruguay

I. Amorín, A. Lescano, N. Ramírez, V. Raggio, R. Buzó (Montevideo, Uruguay)

12:30pm-2:00pm: Dementia in adult type 2 diabetes patients – An analysis from the multicenter German/Austrian diabetes patient follow-up registry DPV

N. Prinz, L. Wang, J. Stingl, M.D. Denkinger, P. Fasching, P.M. Jehle, S. Merger, S. Mühldorfer, A. Schuler, A. Zeyfang, M. Sharma, R.W. Holl (Ulm, Germany)

12:30pm-2:00pm: Demographic feature and clinical characteristic of patients with Parkinson’s disease in Isfahan, Iran

M. Salari (Isfahan, Islamic Republic of Iran)

12:30pm-2:00pm: Development and external validation of a prognostic model of mortality in Parkinson’s disease

A.D. Macleod, I. Dalen, O.B. Tysnes, J.P. Larsen, C.E. Counsell (Aberdeen, United Kingdom)

12:30pm-2:00pm: Dynamics in statin use, low density lipoprotein cholesterol levels and Parkinson’s disease. A population-based cohort study using big-data

V. Rozani, N. Giladi, B. Elad, T. Gurevich, J. Tsamir, B. Hemo, C. Peretz (Petach Tikva, Israel)

12:30pm-2:00pm: Ethnic differences in rates of Parkinson’s in New Zealand: A nation-wide prevalence and incidence study

T.L. Pitcher, D.J. Myall, M.R. MacAskill, J.F. Pearson, C.J. Lacey, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)

12:30pm-2:00pm: Evaluation of the [ 99mTc] – TRODAT- 1 SPECT in the diagnosis of Parkinson’s disease and other movement disorders

G. Fabiani, R. Martins Filho, H.A.G. Teive (Campina Grande do Sul, Brazil)

12:30pm-2:00pm: Frequency of non-motor symptoms in Iranian patients with Parkinson’s disease

M. Salari, O. Mirmosayyeb (Isfahan, Islamic Republic of Iran)

12:30pm-2:00pm: Gender effect on non-motor symptoms in Parkinson’s disease: Are men more at risk for most of them?

R. Vasta, A. Nicoletti, G. Mostile, G. Nicoletti, G. Arabia, G. Iliceto, P. Lamberti, R. Marconi, L. Morgante, P. Barone, A. Quattrone, M. Zappia (Catania, Italy)

12:30pm-2:00pm: Genetic risk of Parkinson’s disease in the general population

S. Darweesh, V. Verlinden, H. Adams, A. Uitterlinden, A. Hofman, B. Stricker, C. van Duijn, P. Koudstaal, M.A. Ikram (Rotterdam, Netherlands)

12:30pm-2:00pm: Impact of cardiovascular risk factors in the evolution and treatment of Parkinson’s disease in Mexican population

G. Parra-López, L. Bazán-Rodríguez, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. Jorge-de Sarachaga, D. Cruz-Fino, J. Pascacio-Astudillo, R. Llorens-Arenas (Mexico City, Mexico)

12:30pm-2:00pm: Impact of neurogenic orthostatic hypotension on healthcare utilization and costs associated with falls in Parkinson’s disease

C. Francois, I. Biaggioni, C.A. Shibao, A. Ogbonnaya, H.C. Shih, E. Farrelly, A. Ziemann, A. Duhig (Deerfield, IL, USA)

12:30pm-2:00pm: Impact of pre- and postdiagnosis physical activity on the progression of Parkinson’s disease

I.F. Shih, K.C. Paul, Y. Bordelon, J.M. Bronstein, B. Ritz (Los Angeles, CA, USA)

12:30pm-2:00pm: Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects

N. Eshakulova, A. Umarov, N. Tuychibaeva, G. Rakhimbaeva, M. Ataniyazov (Tashkent, Uzbekistan)

12:30pm-2:00pm: Parkinson’s in an aging population: Implications from a nation-wide prevalence and incidence study in New Zealand

D.J. Myall, T.L. Pitcher, M.R. MacAskill, J.F. Pearson, C.J. Lacey, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)

12:30pm-2:00pm: Parkinsonian syndrome prevalence in the world

F. Gulyamova (Tashkent, Uzbekistan)

12:30pm-2:00pm: Phenotypic differences between African American and Caucasian Parkinson’s disease patients

M.O. Bailey, B. Ouyang, G.T. Stebbins, L.M. Shulman, L.L. Barnes, D.A. Hall (Chicago, IL, USA)

12:30pm-2:00pm: Physical therapy practice variability and outcomes for people with Parkinson’s disease: Data from the National Parkinson Foundation quality improvement initiative (NPF-QII)

M.R. Rafferty, P.N. Schmidt, S.T. Luo, K. Li, F. Cubillos, C. Marras, T. Davis, E.C. Nelson, T. Simuni (Chicago, IL, USA)

12:30pm-2:00pm: Predictors of transfer to community hospital or nursing home after discharge of inpatients with Parkinson’s disease: A Japanese single center retrospective study

K. Ikeda, K. Takahashi, T. Furuya, A. Miyake, T. Mitsufuji, A. Tanaka, Y. Ito, T. Sasaki, Y. Nakazato, N. Araki, T. Yamamoto (Saitama-ken, Japan)

12:30pm-2:00pm: Prevalence of hemifacial spasm in Northern Cyprus

S. Usar Incirli, F. Selcuk, C.M. Akbostanci (Nicosia, Cyprus)

12:30pm-2:00pm: Prevalence of Parkinson’s disease and myotonic dystrophy in the nomadic population: Mongolian study

T. Sosorburam, B. Samdan, J. Amar (Ulan-Bator, Mongolia)

12:30pm-2:00pm: Prevalence of Parkinson’s disease in the region of Coquimbo, Chile

M. Contreras, P. Pizarro, U. Hernandez, C. Gomez, J. Gajardo (La Serena, Chile)

12:30pm-2:00pm: Prevalence of Parkinson’s disease in Ukraine

Y.O. Trufanov, N.K. Svyrydova, A.I. Galusha, G.M. Chupryna, O.V. Popov, M.V. Nechkalyuk (Kyiv, Ukraine)

12:30pm-2:00pm: Recognition of parkinsonism in African Americans in a community-based sample

D.A. Hall, B. Ouyang, J.M. Shulman, L.M. Shulman, D.A. Bennett, L.L. Barnes (Chicago, IL, USA)

12:30pm-2:00pm: Regular exercise is associated with better two-year outcomes in Parkinson’s disease: National Parkinson foundation quality improvement initiative (NPF-QII) data

M.R. Rafferty, P.N. Schmidt, S.T. Luo, K. Li, F. Cubillos, C. Marras, T. Davis, E.C. Nelson, T. Simuni (Chicago, IL, USA)

12:30pm-2:00pm: Statistical aspects when exploring the association between change in body mass index (BMI), UPDRS scores and survival in the NET PD long-term study-1

A. Perez, A.M. Wills, J. Wang, X. Su, J. Morgan, S.S. Rajan, M. Leehey, G.M. Pontone, K.L. Chou, C. Umeh, Z. Mari, J. Boyd, For the NINDS NET-PD Investigators (Austin, TX, USA)

12:30pm-2:00pm: Survival and risk of mortality of synucleinopathies: A 15 years population-based study (1991 – 2005)

R. Savica, J. Bower, C. Hagen, A.J. Eric, M.M. Mielke (Rochester, MN, USA)

12:30pm-2:00pm: The finger tapping and disrupted smooth pursuit to detect the hepatic encephalopathy: Results of the subgroup analysis of movement disorders in non-Wilsonian hepatic cirrhotic patients

K. Methawasin, P. Chonmaitree, C. Wongjitrat, S. Rattanamongkolgul, T. Asawavichienjinda (Ongkharak, Thailand)

12:30pm-2:00pm: The initial motor symptom of Parkinson’s disease in relation to age at onset and gender: A Sri Lankan perspective

V. Suriyakumara, R. Gamage, H. Gunasekara, T. Fernando, A. Jayasuriya, R. Wijeyekoon, T. Muthukuda, R. De Silva (Nugegoda, Sri Lanka)

12:30pm-2:00pm: The relationship between body composition and postural instability in idiopathic Parkinson’s disease

K.S. Diab, L.A. Hale, D.L. Waters, M.A. Skinner, G. Hammond-Took (Baghdad, Iraq)

12:30pm-2:00pm: The role of diabetes mellitus and hyperglycemia in early de novo Parkinson’s disease patients

S. Polychronis, G. Pagano, M. Politis (London, United Kingdom)

12:30pm-2:00pm: Trajectories of prediagnostic functioning in Parkinson’s disease during 14 years before clinical onset

S. Darweesh, V. Verlinden, B. Stricker, A. Hofman, P. Koudstaal, M.A. Ikram (Rotterdam, Netherlands)

12:30pm-2:00pm: Underutilization of physiotherapy for Parkinson’s disease in the United States

M.E. Fullard, D.P. Thibault, A. Hill, J. Fox, A.W. Willis (Philadelphia, PA, USA)

12:30pm-2:00pm: Work-related stress and risk for Parkinson’s disease

J. Sieurin, R. Andel, E.G. Valdes, N.L. Pedersen, K. Wirdefeldt (Stockholm, Sweden)

« View all sessions from the 20th International Congress.